$0.80
1.00% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US8964383066
Symbol
TRIB

Trinity Biotech Plc Sponsored ADR Class A Stock price

$0.80
-0.31 28.08% 1M
-1.28 61.45% 6M
-1.34 62.62% YTD
-1.15 58.88% 1Y
-6.90 89.59% 3Y
-4.50 84.87% 5Y
-83.20 99.05% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.01 1.00%
ISIN
US8964383066
Symbol
TRIB
Sector

Key metrics

Market capitalization $9.12m
Enterprise Value $100.00m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.69
P/S ratio (TTM) P/S ratio 0.15
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -3.76%
Revenue (TTM) Revenue $59.13m
EBIT (operating result TTM) EBIT $-10.46m
Free Cash Flow (TTM) Free Cash Flow $-15.19m
Cash position $2.84m
EPS (TTM) EPS $-2.26
P/S forward 0.15
EV/Sales forward 1.61
Short interest 2.43%
Show more

Is Trinity Biotech Plc Sponsored ADR Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Trinity Biotech Plc Sponsored ADR Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Trinity Biotech Plc Sponsored ADR Class A:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Trinity Biotech Plc Sponsored ADR Class A:

Buy
100%

Financial data from Trinity Biotech Plc Sponsored ADR Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
59 59
4% 4%
100%
- Direct Costs 40 40
4% 4%
67%
20 20
4% 4%
33%
- Selling and Administrative Expenses 24 24
25% 25%
40%
- Research and Development Expense 4.21 4.21
5% 5%
7%
-8.55 -8.55
46% 46%
-14%
- Depreciation and Amortization 1.90 1.90
4% 4%
3%
EBIT (Operating Income) EBIT -10 -10
41% 41%
-18%
Net Profit -20 -20
29% 29%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about Trinity Biotech Plc Sponsored ADR Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trinity Biotech Plc Sponsored ADR Class A Stock News

Neutral
GlobeNewsWire
5 days ago
DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has entered into amended agreements with its primary lender, Perceptive Advisors. These strategic amendments provide additional liquidity, further enhancing the Com...
Neutral
GlobeNewsWire
11 days ago
DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced an important update on its Comprehensive Transformation Plan, which includes the transfer of manufacturing of both TrinScreen HIV and Uni-Gold HIV to a lower-...
Neutral
Seeking Alpha
about one month ago
Trinity Biotech Plc (NASDAQ:TRIB ) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ET Company Participants Eric Ribner - Investor Relations John Gillard – President, Chief Executive Officer Louise Tallon - Chief Financial Officer Conference Call Participants James Sidoti - Sidoti & Company Paul Nouri – Noble Equity Funds Operator Greetings. Welcome to the Trinity Biotech Third Quart...
More Trinity Biotech Plc Sponsored ADR Class A News

Company Profile

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Head office Ireland
CEO John Gillard
Employees 380
Founded 1992
Website www.trinitybiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today